[go: up one dir, main page]

FI885560A7 - Förfarande för framställning av nya terapeutiskt användbara bisfenylalkylpiperazinderivat - Google Patents

Förfarande för framställning av nya terapeutiskt användbara bisfenylalkylpiperazinderivat

Info

Publication number
FI885560A7
FI885560A7 FI885560A FI885560A FI885560A7 FI 885560 A7 FI885560 A7 FI 885560A7 FI 885560 A FI885560 A FI 885560A FI 885560 A FI885560 A FI 885560A FI 885560 A7 FI885560 A7 FI 885560A7
Authority
FI
Finland
Prior art keywords
bisphenylalkylpiperazine
derivatives
therapeutically useful
preparing novel
novel therapeutically
Prior art date
Application number
FI885560A
Other languages
English (en)
Finnish (fi)
Other versions
FI885560A0 (sv
FI92320C (sv
FI92320B (sv
Inventor
Tomas Fex
Knut Gunnar Olsson
Aina Lisbeth Abramo
Erik Gunnar Christensson
Torbjoern Erik Lundstedt
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of FI885560A0 publication Critical patent/FI885560A0/sv
Publication of FI885560A7 publication Critical patent/FI885560A7/sv
Application granted granted Critical
Publication of FI92320B publication Critical patent/FI92320B/sv
Publication of FI92320C publication Critical patent/FI92320C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI885560A 1987-04-02 1988-11-30 Förfarande för framställning av nya terapeutiskt användbara bisfenylalkylpiperazinderivat FI92320C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8701375A SE8701375D0 (sv) 1987-04-02 1987-04-02 Novel pyridyl- and pyrimidyl derivatives
PCT/SE1988/000144 WO1988007528A1 (en) 1987-04-02 1988-03-25 Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation

Publications (4)

Publication Number Publication Date
FI885560A0 FI885560A0 (sv) 1988-11-30
FI885560A7 true FI885560A7 (sv) 1988-11-30
FI92320B FI92320B (sv) 1994-07-15
FI92320C FI92320C (sv) 1994-10-25

Family

ID=20368077

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885560A FI92320C (sv) 1987-04-02 1988-11-30 Förfarande för framställning av nya terapeutiskt användbara bisfenylalkylpiperazinderivat

Country Status (18)

Country Link
US (1) US4937245A (sv)
EP (1) EP0308476B1 (sv)
JP (1) JPH0819104B2 (sv)
KR (1) KR920003062B1 (sv)
AT (1) ATE85334T1 (sv)
AU (1) AU611147B2 (sv)
CA (1) CA1321997C (sv)
DE (1) DE3878111T2 (sv)
DK (1) DK161313C (sv)
ES (1) ES2006619A6 (sv)
FI (1) FI92320C (sv)
HU (1) HU201051B (sv)
IE (1) IE61165B1 (sv)
IL (1) IL85932A (sv)
NO (1) NO172640C (sv)
NZ (1) NZ224005A (sv)
SE (1) SE8701375D0 (sv)
WO (1) WO1988007528A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US5219855A (en) * 1988-01-29 1993-06-15 Mitsubishi Kasei Corporation Anxiolytic drug
JP2664238B2 (ja) * 1989-03-01 1997-10-15 日清製粉株式会社 ニコチン酸またはそのエステル誘導体
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
EP0580465A1 (fr) * 1992-06-25 1994-01-26 Sanofi Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés
SE9201956D0 (sv) * 1992-06-25 1992-06-25 Kabi Pharmacia Ab Novel nicotinicacid esters
JPH0665203A (ja) * 1992-06-25 1994-03-08 Elf Sanofi ピペラジンのヘテロ環誘導体
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives
DK139593D0 (da) * 1993-12-16 1993-12-16 Lundbeck & Co As H Compounds
EE04588B1 (et) 1997-10-27 2006-02-15 Neurosearch A/S Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
MXPA01010176A (es) * 1999-04-09 2002-03-27 Meiji Seika Kaisha Compuestos heterociclicos que contienen nitrogeno y compuestos de benzamida y farmacos que los contienen.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2958694A (en) * 1959-06-22 1960-11-01 Janssen Paul Adriaan Jan 1-(aroylalkyl)-4-(2'-pyridyl) piperazines
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
JPS6081167A (ja) * 1983-10-11 1985-05-09 Sumitomo Chem Co Ltd フエニルアセトン誘導体およびその製造法
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
JPS6175A (ja) * 1984-03-06 1986-01-06 ブリストル−マイア−ズ　コムパニ− 神経弛緩剤、１‐フルオロフェニルブチル‐４‐（５‐ハロ‐２‐ピリミジニル）ピペラジン誘導体
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
JPS63146872A (ja) * 1986-07-08 1988-06-18 Yoshitomi Pharmaceut Ind Ltd ピリミジニルピペラジン化合物
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives

Also Published As

Publication number Publication date
DK161313B (da) 1991-06-24
DK161313C (da) 1991-12-30
NZ224005A (en) 1991-03-26
FI885560A0 (sv) 1988-11-30
DK671588D0 (da) 1988-12-01
FI92320C (sv) 1994-10-25
IE880869L (en) 1988-10-02
JPH0819104B2 (ja) 1996-02-28
IL85932A (en) 1993-05-13
IE61165B1 (en) 1994-10-05
NO885386L (no) 1988-12-02
NO885386D0 (no) 1988-12-02
WO1988007528A1 (en) 1988-10-06
US4937245A (en) 1990-06-26
SE8701375D0 (sv) 1987-04-02
KR920003062B1 (ko) 1992-04-13
HUT50325A (en) 1990-01-29
DK671588A (da) 1988-12-01
EP0308476B1 (en) 1993-02-03
CA1321997C (en) 1993-09-07
EP0308476A1 (en) 1989-03-29
JPH01502832A (ja) 1989-09-28
NO172640C (no) 1993-08-18
HU201051B (en) 1990-09-28
AU1579688A (en) 1988-11-02
KR880012586A (ko) 1988-11-28
DE3878111D1 (de) 1993-03-18
FI92320B (sv) 1994-07-15
DE3878111T2 (de) 1993-07-01
IL85932A0 (en) 1988-09-30
AU611147B2 (en) 1991-06-06
NO172640B (no) 1993-05-10
ATE85334T1 (de) 1993-02-15
ES2006619A6 (es) 1989-05-01

Similar Documents

Publication Publication Date Title
FI885409A7 (sv) Förfarande för framställning av nya terapeutiskt användbara pyridazinaminderivat
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI881180L (sv) Förfarande för framställning av terapeutiskt användbara tetrahydronaftalenderivat
FI883249A7 (sv) Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat
FI883064A7 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI883050L (sv) Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivat
FI905941A7 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI893433A7 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI880816A7 (sv) Förfarande för framställning av nya terapeutiskt användbara kinoxalinderivat
FI883388L (sv) Förfarande för framställning av nya terapeutiskt användbara peptider
FI906438L (sv) Förfarande för framställning av nya, terapeutiskt användbara A-nor-steroid-3-karboxylsyraderivat
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI884627A7 (sv) Förfarande för framställning av nya terapeutiskt användbara dideoxicytidinderivat
FI883603A7 (sv) Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat
FI884553A7 (sv) Analogiförfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridinderivat
FI891339A7 (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI890283A7 (sv) Förfarande för framställning av terapeutiskt användbara 25-hydroxi-vitamin D-derivat
FI883672A7 (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI883889A7 (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI894803L (sv) Förfarande för framställning av terapeutiskt användbara kinolinonderivat
FI884910A7 (sv) Förfarande för framställning av terapeutiskt användbart bensopyranderivat
FI883997L (sv) Förfarande för framställning av terapeutiskt användbara substituerade 2-fenyl-4-kinolinkarboxylsyror
FI880467A7 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI881525A7 (sv) Förfarande för framställning av nya terapeutiskt användbara N-arylpiperazinacetamidderivat
FI885560A7 (sv) Förfarande för framställning av nya terapeutiskt användbara bisfenylalkylpiperazinderivat

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: PHARMACIA AB

FG Patent granted

Owner name: BIOVITRUM AB

MA Patent expired